AI-enabled plaque assessments help cardiologists ID high-risk CAD patients

Using advanced artificial intelligence (AI) platforms to assess imaging results and quantify coronary plaque buildup can help clinicians predict adverse events in patients with suspected coronary artery disease (CAD), according to late-breaking data presented at TCT 2024 in Washington, D.C.

Alexander R. van Rosendael, MD, PhD, presents late-breaking data on AI-enabled coronary plaque assessments at TCT 2024.

AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.